Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis

Gut

Volumn 59, Issue 1, 2010, Pages 12-20

  Vicario, M ^a,b   Blanchard, C ^a   Stringer, K F ^a   Collins, M H ^a   Mingler, M K ^a   Ahrens, A ^a   Putnam, P E ^a   Abonia, J P ^a   Santos, J ^b   Rothenberg, M E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE DEAMINASE; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; RNA;

ADOLESCENT; ANTIBODY PRODUCTION; ARTICLE; ATOPY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL DENSITY; CHILD; CLASS SWITCH RECOMBINATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSCOPIC BIOPSY; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS MUCOSA; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; MUCOSAL IMMUNITY; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD;

ADOLESCENT; B-LYMPHOCYTES; CELL COUNT; CHILD; CHILD, PRESCHOOL; EOSINOPHILIA; ESOPHAGITIS; ESOPHAGUS; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; INTERLEUKIN-13; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MALE; MAST CELLS; MUCOUS MEMBRANE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 73449091211     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.178020     Document Type: Article

References (48)

1. Fox VL, Nurko S, Furuta GT. Eosinophilic esophagitis: it's not just kid's stuff. Gastrointestinal Endosc 2002;56:260-70.
2. Orenstein SR, Shalaby TM, Di Lorenzo C, et al. The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol 2000;95:1422-30.
3. Straumann A, Spichtin HP, Grize L, et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 2003;125:1660-9.
4. Kerlin P, Jones D, Remedios M, et al. Prevalence of eosinophilic esophagitis in adults with food bolus obstruction of the esophagus. J Clin Gastroenterol 2007;41:356-61.
5. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med 2004;351:940-1.
6. Collins MH, Blanchard C, Abonia JP, et al. Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin Gastroenterol Hepathol 2008;6:621-9.
7. Stainer SJ, Gupta SK, Croffie JM, et al. Correlation between number of eosinophils and reflux index on same day esophageal biopsy and 24 hour esophageal pH monitoring. Am J Gastroenterol 2004;99:801-5.
8. Walsh SV, Antonioli DA, Goldman H, et al. Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol 1999;23:390-6.
9. Rothenberg ME, Mishra A, Collins MH, et al. Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Immunol 2001;108:891-4.
10. Blanchard C, Wang N, Stringer KF, et al. Eotaxin-3 and a uniquely conserved geneexpression profile in eosinophilic esophagitis. J Clin Invest 2006;116:536-47.
11. Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2004;113:11-28.
12. Assa'ad A. Eosinophilic esophagitis: association with allergic disorders. Gastrointest Endoscopy Clin N Am 2008;18:119-32.
13. Roy-Ghanta S, Larosa DF, Katzka DA. Atopic characteristics of adult patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2008;6:531-5.
14. Markowitz JE, Spergel JM, Ruchelli E, et al. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol 2003;98:777-82.
15. Kagalwalla AF, Sentongo TA, Ritz S, et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol 2006;4:1097-102.
16. Spergel JM, Andrews T, Brown-Whitehorn TF, et al. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol 2005;95:336-43.
17. Kirsch R, Bokhary R, Marcon MA, et al. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2007;44:20-6.
18. Lucendo AJ, Navarro M, Comas C, et al. Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through steorology. Am J Surg Pathol 2007;31:598-606.
19. Straumann A, Bauer M, Fischer B, et al. Idiopathic eosinophilic esophagitis is associated with a Th2-type allergic inflammatory response. J Allergy Clin Immunol 2001;108:954-61.
20. Collins MH. Histopathologic features of eosinophilic esophagitis. Gastrointest Endosc Clin N Am 2008;18:59-71.
21. Blanchard C, Rothenberg ME. Basic pathogenesis of eosinophilic esophagitis. Gastrointest Endosc Clin N Am 2008;18:133-43.
22. Blanchard C, Mingler MK, Vicario M, et al. IL-13 involvement in eosinophilic esophagitis: Transcriptome analysis and reversivility with glucocorticoids. J Allergy Clin Immunol 2007;120:1292-300.
23. Gould HJ, Sutton BJ, Beavil AJ, et al. The biology of IgE and the basis of allergic disease. Annu Rev Immunol 2003;21:579- 628.
24. Stavnezer J. Antibody class switching. Adv Immunol 1996;61:79-146.
25. Cerutti A, Zan H, Schaffer A, et al. CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line. J Immunol 1998;160:2145-57.
26. Muramatsu M, Kinoshita K, Fagarasan S, et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000;102:553-63.
27. Stavnezer J, Guikema EJ, Schrader C. Mechanism and regulation of class switch recombination. Annu Rev Immunol 2008;26:261-92.
28. Liu YJ, Malisan F, de Bouteiller O, et al. Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity 1996;4:241-50.
29. Toellner KM, Gulbranson JA, Taylor DR, et al. Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation. J Exp Med 1996;183:2303- 12.
30. Fagarasan S, Kinosita K, Muramatsu M, et al. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 2001;413:639-43.
31. Fagarasan S, Muramatsu M, Suzuki K, et al. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 2002;298:1424-7.
32. Takhar P, Smurthwaite L, Coker HA, et al. Allergen drives class switch to IgE in the nasal mucosa in allergic rhinitis. J Immunol 2005;174:5024-32.
33. Takhar P, Corrigan CJ, Smurthwaite L, et al. Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma. J Allergy Clin Immunol 2007;119:213-8.
34. Waldmann T, Iio A, Ogawa M, et al. The metabolism of IgE. Studies in normal individuals and in a patient with IgE myeloma. J Immunol 1976;117:1139-44.
35. Matsumoto K, Shimada T, Uchida Y. Morphology of the lamina propria in the esophagus with special reference to he proprial papillae. Med Electron Microsc 1997;30:15-24.
36. Zimmermann N, King NE, Laporte J, et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 2003;111:1863-74.
37. Ravetch JV, Siebenlist U, Korsmeyer S, et al. Structure of the human immunoglobulin mu locus: characterization of embryonic and rearranged J and D genes. Cell 1981;27:583-91.
38. Gould HJ, Takhar P, Harries HE, et al. Germinal-centre reactions in allergic inflammation. Trends Immunol 2006;27:446-52.
39. Kinoshita K, Harigai M, Fagarasan S, et al. A hallmark of active class switch recombination: transcripts directed by I promoters on looped out circular DNAs. Proc Natl Acad Sci USA 2001;98:12620-3.
40. MacDonanld KPA, Nishioka Y, Lipsky PE, et al. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest 1997;100:2404-14.
41. McHeyzer-Williams JL, McHeyzer-Williams MG. Antigen-specific memory B cell development. Annu Rev Immunol 2005;23:487-513.
42. Misha A, Hogan SP, Brandt EB, et al. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 2001;107:83-90.
43. Cocks BG, de Waal Malefiyt R, Galizzi JP, et al. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol 1993;5:657-63.
44. Sehra S, Bruns HA, Ahyi AN, et al. IL-4 is a critical determinant in the generation of allergic inflammation initiated by a constitutively active STAT6. J Immunol 2008;180:3551-9.
45. Piliponsky AM, Gleich GJ, Bar I, et al. Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation. Mol Immunol 2002;38:1369-72.
46. Kita H, Kaneko M, Bartemes KR, et al. Does IgE bind to and activate eosinophils from patients with allergy? J Immunol 1999;162:6901-11.
47. KleiJan A, Vinke JG, Severijnen LW, et al. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J 2000;15:491-7.
48. Koshland ME. The coming of age of the immunoglobulin J chain. Annu Rev Immunol 1985;3:425-53.